Alpha-Amyrin palmitate exhibits antiarthritic activity in a rat adjuvant-induced arthritis model. In vitro, it acts as a potent non-competitive chymotrypsin inhibitor (Ki=6 µM) and demonstrates weak cytotoxicity against A2780 human ovarian cancer cells, supporting research in inflammation, enzymology, and oncology.